Didier Lepelletier1,2, Christian Chidiac1,3,4, Zeina Mansour1,5, Franck Chauvin1,6. 1. High Council for Public Health Ministry of Health Paris France. 2. Hospital Hygiene Department Nantes University Hospital, France; UR 1155 - Nantes University, IICiMed, Institut de Recherche en Santé 2 Nantes France. 3. Department of Infectious and Tropical Diseases Lyon University Hospital Lyon France. 4. CIRI équipe PH3ID-INSERM-U1111-Université Claude Bernard Lyon 1-CNRS - UMR5308-ENS de Lyon Lyon France. 5. Regional Committee for Health Education Provence Alpes Côte d'Azur (PACA) France. 6. Centre Hygée, Institut Presage, CIC-EC Inserm 1408 University of Saint-Etienne Saint-Etienne France.
Abstract
Introduction: The objectives were to elaborate new recommendations for the French Government taking into account the new epidemiological situation due to Omicron variant of SARS-CoV-2 virus and to maintain essential functions of the State through socioeconomic and health life. Method: Two self-decision matrix were built for isolation (cases) and quarantine (contacts) and for citizen testing, respectively. The recommendations included in the two matrix were validated internally by experts and scientists from the scientist literature. Results: A strategic breakdown into five phases corresponding to the possible phases of Omicron variants spread was built. Exceptional and transitory derogation for essential activities was proposed in fully vaccinated professionals. Suspension of quarantine period for fully vaccinated contacts and professionals was proposed with routine self-testing program. Conclusion: These new HCSP guidelines aims to preserve public health as a whole and to minimize the socioeconomic and health consequences linked to the emergence of the Omicron variant by making trade-offs/adaptations in dependent scientist contexts. Patient or Public Contribution: HCSP scientists and experts were in charge of drafting the recommendations and promoting them to the Government for their application by regulatory decree voted by law.
Introduction: The objectives were to elaborate new recommendations for the French Government taking into account the new epidemiological situation due to Omicron variant of SARS-CoV-2 virus and to maintain essential functions of the State through socioeconomic and health life. Method: Two self-decision matrix were built for isolation (cases) and quarantine (contacts) and for citizen testing, respectively. The recommendations included in the two matrix were validated internally by experts and scientists from the scientist literature. Results: A strategic breakdown into five phases corresponding to the possible phases of Omicron variants spread was built. Exceptional and transitory derogation for essential activities was proposed in fully vaccinated professionals. Suspension of quarantine period for fully vaccinated contacts and professionals was proposed with routine self-testing program. Conclusion: These new HCSP guidelines aims to preserve public health as a whole and to minimize the socioeconomic and health consequences linked to the emergence of the Omicron variant by making trade-offs/adaptations in dependent scientist contexts. Patient or Public Contribution: HCSP scientists and experts were in charge of drafting the recommendations and promoting them to the Government for their application by regulatory decree voted by law.
Authors: Nick Andrews; Elise Tessier; Julia Stowe; Charlotte Gower; Freja Kirsebom; Ruth Simmons; Eileen Gallagher; Simon Thelwall; Natalie Groves; Gavin Dabrera; Richard Myers; Colin N J Campbell; Gayatri Amirthalingam; Matt Edmunds; Maria Zambon; Kevin Brown; Susan Hopkins; Meera Chand; Shamez N Ladhani; Mary Ramsay; Jamie Lopez Bernal Journal: N Engl J Med Date: 2022-01-12 Impact factor: 91.245
Authors: Rolando Pajon; Nicole A Doria-Rose; Xiaoying Shen; Stephen D Schmidt; Sijy O'Dell; Charlene McDanal; Wenhong Feng; Jin Tong; Amanda Eaton; Maha Maglinao; Haili Tang; Kelly E Manning; Venkata-Viswanadh Edara; Lilin Lai; Madison Ellis; Kathryn M Moore; Katharine Floyd; Stephanie L Foster; Christine M Posavad; Robert L Atmar; Kirsten E Lyke; Tongqing Zhou; Lingshu Wang; Yi Zhang; Martin R Gaudinski; Walker P Black; Ingelise Gordon; Mercy Guech; Julie E Ledgerwood; John N Misasi; Alicia Widge; Nancy J Sullivan; Paul C Roberts; John H Beigel; Bette Korber; Lindsey R Baden; Hana El Sahly; Spyros Chalkias; Honghong Zhou; Jing Feng; Bethany Girard; Rituparna Das; Anne Aunins; Darin K Edwards; Mehul S Suthar; John R Mascola; David C Montefiori Journal: N Engl J Med Date: 2022-01-26 Impact factor: 176.079
Authors: Nick Andrews; Julia Stowe; Freja Kirsebom; Samuel Toffa; Tim Rickeard; Eileen Gallagher; Charlotte Gower; Meaghan Kall; Natalie Groves; Anne-Marie O'Connell; David Simons; Paula B Blomquist; Asad Zaidi; Sophie Nash; Nurin Iwani Binti Abdul Aziz; Simon Thelwall; Gavin Dabrera; Richard Myers; Gayatri Amirthalingam; Saheer Gharbia; Jeffrey C Barrett; Richard Elson; Shamez N Ladhani; Neil Ferguson; Maria Zambon; Colin N J Campbell; Kevin Brown; Susan Hopkins; Meera Chand; Mary Ramsay; Jamie Lopez Bernal Journal: N Engl J Med Date: 2022-03-02 Impact factor: 91.245
Authors: Eddy Pérez-Then; Carolina Lucas; Valter Silva Monteiro; Marija Miric; Vivian Brache; Leila Cochon; Chantal B F Vogels; Amyn A Malik; Elena De la Cruz; Aidelis Jorge; Margarita De Los Santos; Patricia Leon; Mallery I Breban; Kendall Billig; Inci Yildirim; Claire Pearson; Randy Downing; Emily Gagnon; Anthony Muyombwe; Jafar Razeq; Melissa Campbell; Albert I Ko; Saad B Omer; Nathan D Grubaugh; Sten H Vermund; Akiko Iwasaki Journal: Nat Med Date: 2022-01-20 Impact factor: 53.440